-
1
-
-
0141651951
-
Polymyositis and dermatomyositis
-
Dalakas MC, Hohlfeld R,. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-982.
-
(2003)
Lancet
, vol.362
, pp. 971-982
-
-
Dalakas, M.C.1
Hohlfeld, R.2
-
2
-
-
0036108902
-
Outcome in patients with idiopathic inflammatory myositis: Morbidity and mortality
-
Sultan SM, Ioannou Y, Moss K, Isenberg DA,. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 2002; 41: 22-26.
-
(2002)
Rheumatology
, vol.41
, pp. 22-26
-
-
Sultan, S.M.1
Ioannou, Y.2
Moss, K.3
Isenberg, D.A.4
-
3
-
-
1642494599
-
Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: A longitudinal study of 162 cases
-
Danko K, Ponyi A, Constantin T, Borgulya G, Szegedi G,. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 2004; 83: 35-42.
-
(2004)
Medicine
, vol.83
, pp. 35-42
-
-
Danko, K.1
Ponyi, A.2
Constantin, T.3
Borgulya, G.4
Szegedi, G.5
-
4
-
-
0017640201
-
Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis
-
Bohan A, Peter JB, Bowman RL, Bowman RL, Pearson CM,. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977; 56: 255-286.
-
(1977)
Medicine
, vol.56
, pp. 255-286
-
-
Bohan, A.1
Peter, J.B.2
Bowman, R.L.3
Bowman, R.L.4
Pearson, C.M.5
-
5
-
-
37749038565
-
Systemic lupus erythematosus and "lupus dyslipoproteinemia"
-
de Carvalho JF, Bonfá E, Borba EF,. Systemic lupus erythematosus and "lupus dyslipoproteinemia". Autoimmun Rev 2008; 7: 246-250.
-
(2008)
Autoimmun Rev
, vol.7
, pp. 246-250
-
-
De Carvalho, J.F.1
Bonfá, E.2
Borba, E.F.3
-
6
-
-
62849084638
-
Lipid profiles in patients with rheumatoid arthritis: Mechanisms and the impact of treatment
-
Steiner G, Urowitz MB,. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 2009; 38: 372-381.
-
(2009)
Semin Arthritis Rheum
, vol.38
, pp. 372-381
-
-
Steiner, G.1
Urowitz, M.B.2
-
7
-
-
33645292926
-
Serum lipid levels in Sjogren's syndrome
-
Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR,. Serum lipid levels in Sjogren's syndrome. Rheumatology 2006; 45: 481-484.
-
(2006)
Rheumatology
, vol.45
, pp. 481-484
-
-
Lodde, B.M.1
Sankar, V.2
Kok, M.R.3
Leakan, R.A.4
Tak, P.P.5
Pillemer, S.R.6
-
8
-
-
33845680179
-
Mechanisms of dyslipoproteinemias in systemic lupus erythematosus
-
Borba EF, Carvalho JF, Bonfá E,. Mechanisms of dyslipoproteinemias in systemic lupus erythematosus. Clin Dev Immunol 2006; 13: 203-208.
-
(2006)
Clin Dev Immunol
, vol.13
, pp. 203-208
-
-
Borba, E.F.1
Carvalho, J.F.2
Bonfá, E.3
-
9
-
-
70449688271
-
Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus
-
Reiss AB,. Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus. Curr Rheumatol Rep 2009; 11: 255-260.
-
(2009)
Curr Rheumatol Rep
, vol.11
, pp. 255-260
-
-
Reiss, A.B.1
-
10
-
-
33751291002
-
Patterns of cardiovascular risk in rheumatoid arthritis
-
Solomon DH, Goodson NJ, Katz JN, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1608-1612.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 1608-1612
-
-
Solomon, D.H.1
Goodson, N.J.2
Katz, J.N.3
-
11
-
-
34248585897
-
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus
-
Westerweel PE, Luyten RK, Koomans HA, Derksen RH, Verhaar MC,. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1384-1396.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 1384-1396
-
-
Westerweel, P.E.1
Luyten, R.K.2
Koomans, H.A.3
Derksen, R.H.4
Verhaar, M.C.5
-
12
-
-
0016850495
-
Polymyositis and dermatomyositis
-
Bohan A, Peter JB,. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-347.
-
(1975)
N Engl J Med
, vol.292
, pp. 344-347
-
-
Bohan, A.1
Peter, J.B.2
-
13
-
-
32644437182
-
Mechanisms of disease: Atherosclerosis in autoimmune diseases
-
Sherer Y, Shoenfeld Y,. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006; 2: 99-106.
-
(2006)
Nat Clin Pract Rheumatol
, vol.2
, pp. 99-106
-
-
Sherer, Y.1
Shoenfeld, Y.2
-
14
-
-
24144438580
-
Atherosclerosis in patients with autoimmune disorders
-
Frostegård J,. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005; 25: 1776-1785.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1776-1785
-
-
Frostegård, J.1
-
15
-
-
80054752325
-
Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis
-
Eimer MJ, Brickman WJ, Seshadri R, et al. Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis. J Pediatr 2011; 159: 795-801.
-
(2011)
J Pediatr
, vol.159
, pp. 795-801
-
-
Eimer, M.J.1
Brickman, W.J.2
Seshadri, R.3
-
16
-
-
34247550873
-
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: Effect of early treatment-a prospective, controlled study
-
Georgiadis AN, Papavasiliou EC, Lourida ES, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res Ther 2006; 8: R82.
-
(2006)
Arthritis Res Ther
, vol.8
-
-
Georgiadis, A.N.1
Papavasiliou, E.C.2
Lourida, E.S.3
-
17
-
-
28844454106
-
Lipid profiles among US elderly with untreated rheumatoid arthritis - The Third National Health and Nutrition Examination Survey
-
Choi HK, Seeger JD,. Lipid profiles among US elderly with untreated rheumatoid arthritis-the Third National Health and Nutrition Examination Survey. J Rheumatol 2005; 32: 2311-2316.
-
(2005)
J Rheumatol
, vol.32
, pp. 2311-2316
-
-
Choi, H.K.1
Seeger, J.D.2
-
18
-
-
0008856783
-
Lipid profiles in untreated patients with rheumatoid arthritis
-
Park YB, Lee SK, Lee WK, et al. Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1701-1704.
-
(1999)
J Rheumatol
, vol.26
, pp. 1701-1704
-
-
Park, Y.B.1
Lee, S.K.2
Lee, W.K.3
-
19
-
-
20044362604
-
Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: Serum levels and relationship to inflammation
-
Dursunoglu D, Evrengul H, Polat B, et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 2005; 25: 241-245.
-
(2005)
Rheumatol Int
, vol.25
, pp. 241-245
-
-
Dursunoglu, D.1
Evrengul, H.2
Polat, B.3
-
20
-
-
0025239836
-
Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders; Prevalence and clinical significance
-
Love PE, Santoro SA,. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders; prevalence and clinical significance. Ann Intern Med 1990; 112: 682-698.
-
(1990)
Ann Intern Med
, vol.112
, pp. 682-698
-
-
Love, P.E.1
Santoro, S.A.2
-
21
-
-
17144377882
-
Anti-lipoprotein lipase antibody in systemic sclerosis: Association with elevated serum triglyceride concentrations
-
Kodera M, Hayakawa I, Komura K, et al. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. J Rheumatol 2005; 32: 629-636.
-
(2005)
J Rheumatol
, vol.32
, pp. 629-636
-
-
Kodera, M.1
Hayakawa, I.2
Komura, K.3
-
22
-
-
0041569770
-
Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
-
Delgado AJ, Kumar S, Isenberg DA,. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 2003; 42: 893-899.
-
(2003)
Rheumatology
, vol.42
, pp. 893-899
-
-
Delgado, A.J.1
Kumar, S.2
Isenberg, D.A.3
-
23
-
-
0034130314
-
Chylomicron metabolism is markedly altered in systemic lupus erythematosus
-
Borba EF, Bonfa E, Vinagre CG, Ramires JA, Maranhao RC,. Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 1033-1040.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1033-1040
-
-
Borba, E.F.1
Bonfa, E.2
Vinagre, C.G.3
Ramires, J.A.4
Maranhao, R.C.5
-
24
-
-
0030758970
-
Dyslipoproteinemias in systemic lupus erythematosus: Influence of disease, activity, and anticardiolipin antibodies
-
Borba EF, Bonfa E,. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997; 6: 533-539.
-
(1997)
Lupus
, vol.6
, pp. 533-539
-
-
Borba, E.F.1
Bonfa, E.2
-
25
-
-
0023684531
-
A phase i trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients
-
Feinberg B, Kurzrock R, Talpaz M, Blick M, Saks S, Gutterman JU,. A phase I trial of intravenously administered recombinant tumor necrosis factor-alpha in cancer patients. J Clin Oncol 1988; 6: 1328-1334.
-
(1988)
J Clin Oncol
, vol.6
, pp. 1328-1334
-
-
Feinberg, B.1
Kurzrock, R.2
Talpaz, M.3
Blick, M.4
Saks, S.5
Gutterman, J.U.6
-
26
-
-
0141676423
-
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus
-
Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegård J,. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum 2003; 48: 2533-2540.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2533-2540
-
-
Svenungsson, E.1
Gunnarsson, I.2
Fei, G.Z.3
Lundberg, I.E.4
Klareskog, L.5
Frostegård, J.6
-
27
-
-
13244252637
-
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
-
Popa C, Netea MG, Radstake T, et al. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 2005; 64: 303-305.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 303-305
-
-
Popa, C.1
Netea, M.G.2
Radstake, T.3
-
28
-
-
2642579895
-
CRP as a mediator of disease
-
Yeh ETH,. CRP as a mediator of disease. Circulation 2004; 109: 11-14.
-
(2004)
Circulation
, vol.109
, pp. 11-14
-
-
Yeh, E.T.H.1
-
29
-
-
33644682193
-
Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: Relationship to cardiovascular risk factors
-
Asanuma Y, Chung CP, Oeser A, et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol 2006; 33: 539-545.
-
(2006)
J Rheumatol
, vol.33
, pp. 539-545
-
-
Asanuma, Y.1
Chung, C.P.2
Oeser, A.3
-
30
-
-
67349169971
-
High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis
-
de Carvalho JF, Bonfá E, Bezerra MC, Pereira RM,. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clin Rheumatol 2009; 28: 801-805.
-
(2009)
Clin Rheumatol
, vol.28
, pp. 801-805
-
-
De Carvalho, J.F.1
Bonfá, E.2
Bezerra, M.C.3
Pereira, R.M.4
-
31
-
-
8444224272
-
Anti-lipoprotein lipase antibodies: A new player in the complex atherosclerotic process in systemic lupus erythematosus?
-
de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E,. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 2004; 50: 3610-3615.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 3610-3615
-
-
De Carvalho, J.F.1
Borba, E.F.2
Viana, V.S.3
Bueno, C.4
Leon, E.P.5
Bonfá, E.6
-
32
-
-
0346333033
-
Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction
-
Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR,. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004; 93: 198-200.
-
(2004)
Am J Cardiol
, vol.93
, pp. 198-200
-
-
Fischer, L.M.1
Schlienger, R.G.2
Matter, C.3
Jick, H.4
Meier, C.R.5
-
33
-
-
0034761724
-
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus
-
Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331-2337.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2331-2337
-
-
Esdaile, J.M.1
Abrahamowicz, M.2
Grodzicky, T.3
|